# Labcorp Holdings Inc.: filings

LH · NYSE · CIK 920148 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lh.md) · [Financials](/companies/lh/financials.md) · [Filings](/companies/lh/filings.md) · [Insiders](/companies/lh/insiders.md)

## Reports and events: 794 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1163, 8-K 680, 144 64, 10-Q 54, SC 13G/A 52, 3 46, SC TO-T/A 27, DEFA14A 19, 10-K 18, DEF 14A 18, S-8 POS 18, 425 17, 424B5 16, SD 13, UPLOAD 13, 8-K/A 12, ARS 11, SC 13G 10, CORRESP 9, 4/A 8, FWP 8, S-3ASR 6, S-8 6, 10-K/A 4, SC TO-C 4, 10-Q/A 3, 5 3, SC 13D/A 3, SC TO-T 3, 3/A 2, PX14A6G 2, SC 13D 2, SCHEDULE 13G/A 2, 144/A 1, 15-12G 1, 25-NSE 1, 305B2 1, 424B3 1, 8-K12B 1, EFFECT 1, POSASR 1, S-4 1, S-4/A 1, SCHEDULE 13G 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:11 ET | [10-Q](/filings/0000920148-26-000222.md) | Quarterly report, period 2026-09-30 | 0000920148-26-000222 |
| 2026-10-28 | 06:57 ET | [8-K](/filings/0000920148-26-000213.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-26-000213 |
| 2026-10-21 | 06:51 ET | [8-K](/filings/0000920148-26-000210.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000210 |
| 2026-09-30 | 08:32 ET | [8-K](/filings/0000920148-26-000207.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000207 |
| 2026-09-22 | 16:43 ET | [8-K](/filings/0000920148-26-000205.md) | 7.01 Regulation FD disclosure | 0000920148-26-000205 |
| 2026-09-10 | 16:47 ET | [8-K](/filings/0000920148-26-000201.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000201 |
| 2026-08-28 | 08:33 ET | [8-K](/filings/0000920148-26-000189.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000189 |
| 2026-08-17 | 08:03 ET | [8-K](/filings/0000920148-26-000185.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000185 |
| 2026-08-14 | 08:55 ET | [8-K](/filings/0000920148-26-000182.md) | 5.02 Departure or appointment of officers or directors | 0000920148-26-000182 |
| 2026-08-05 | 16:15 ET | [10-Q](/filings/0000920148-26-000175.md) | Quarterly report, period 2026-06-30 | 0000920148-26-000175 |
| 2026-07-30 | 06:53 ET | [8-K](/filings/0000920148-26-000162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-26-000162 |
| 2026-07-10 | 07:31 ET | [8-K](/filings/0000920148-26-000157.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000157 |
| 2026-06-30 | 16:20 ET | [8-K](/filings/0000920148-26-000150.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000150 |
| 2026-05-27 | 08:04 ET | [8-K](/filings/0000920148-26-000147.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000147 |
| 2026-05-26 | 16:01 ET | [8-K](/filings/0000920148-26-000143.md) | 5.07 Shareholder vote results | 0000920148-26-000143 |
| 2026-05-04 | 14:10 ET | [10-Q](/filings/0000920148-26-000139.md) | Quarterly report, period 2026-03-31 | 0000920148-26-000139 |
| 2026-04-30 | 06:57 ET | [8-K](/filings/0000920148-26-000135.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-26-000135 |
| 2026-04-10 | 12:01 ET | [DEF 14A](/filings/0001193125-26-150752.md) | Proxy statement, period 2026-04-10 | 0001193125-26-150752 |
| 2026-04-09 | 06:54 ET | [8-K](/filings/0000920148-26-000131.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000131 |
| 2026-03-31 | 16:21 ET | [8-K](/filings/0000920148-26-000128.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000128 |
| 2026-03-20 | 17:01 ET | [8-K](/filings/0001193125-26-117879.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-117879 |
| 2026-02-24 | 13:51 ET | [10-K](/filings/0000920148-26-000111.md) | Annual report, period 2025-12-31 | 0000920148-26-000111 |
| 2026-02-17 | 06:54 ET | [8-K](/filings/0000920148-26-000098.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-26-000098 |
| 2026-02-09 | 08:34 ET | [8-K](/filings/0000920148-26-000019.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000019 |
| 2026-01-29 | 16:15 ET | [8-K](/filings/0000920148-26-000017.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000920148-26-000017 |
| 2026-01-15 | 16:21 ET | [8-K](/filings/0000920148-26-000013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000013 |
| 2026-01-14 | 06:53 ET | [8-K](/filings/0000920148-26-000009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-26-000009 |
| 2025-12-30 | 16:17 ET | [8-K](/filings/0000920148-25-000125.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000125 |
| 2025-12-15 | 16:03 ET | [8-K](/filings/0000920148-25-000123.md) | 5.02 Departure or appointment of officers or directors | 0000920148-25-000123 |
| 2025-12-10 | 16:23 ET | [8-K](/filings/0000920148-25-000120.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000120 |
| 2025-11-24 | 08:33 ET | [8-K](/filings/0000920148-25-000111.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000111 |
| 2025-10-31 | 12:06 ET | [10-Q](/filings/0000920148-25-000096.md) | Quarterly report, period 2025-09-30 | 0000920148-25-000096 |
| 2025-10-28 | 06:55 ET | [8-K](/filings/0000920148-25-000093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-25-000093 |
| 2025-10-08 | 16:20 ET | [8-K](/filings/0000920148-25-000091.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000091 |
| 2025-09-25 | 16:29 ET | [8-K](/filings/0000920148-25-000088.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000088 |
| 2025-08-28 | 16:10 ET | [8-K](/filings/0000920148-25-000085.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000085 |
| 2025-08-01 | 13:25 ET | [10-Q](/filings/0000920148-25-000081.md) | Quarterly report, period 2025-06-30 | 0000920148-25-000081 |
| 2025-07-24 | 06:52 ET | [8-K](/filings/0000920148-25-000075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-25-000075 |
| 2025-07-10 | 06:58 ET | [8-K](/filings/0000920148-25-000073.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000073 |
| 2025-06-27 | 16:16 ET | [8-K](/filings/0001193125-25-151281.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-151281 |
| 2025-06-26 | 16:12 ET | [8-K](/filings/0000920148-25-000071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000071 |
| 2025-05-20 | 07:45 ET | [8-K](/filings/0000920148-25-000069.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000920148-25-000069 |
| 2025-05-08 | 16:17 ET | [8-K](/filings/0000920148-25-000064.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000064 |
| 2025-04-29 | 11:34 ET | [10-Q](/filings/0000920148-25-000059.md) | Quarterly report, period 2025-03-31 | 0000920148-25-000059 |
| 2025-04-29 | 06:53 ET | [8-K](/filings/0000920148-25-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-25-000054 |
| 2025-04-10 | 06:52 ET | [8-K](/filings/0000920148-25-000047.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000047 |
| 2025-04-04 | 08:00 ET | [DEF 14A](/filings/0001193125-25-072853.md) | Proxy statement, period 2025-05-15 | 0001193125-25-072853 |
| 2025-03-31 | 16:19 ET | [8-K](/filings/0000920148-25-000044.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000920148-25-000044 |
| 2025-02-25 | 12:58 ET | [10-K](/filings/0000920148-25-000032.md) | Annual report, period 2024-12-31 | 0000920148-25-000032 |
| 2025-02-06 | 06:54 ET | [8-K](/filings/0000920148-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000920148-25-000021 |

Page 1 of 16. [Older](/companies/lh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:19 ET. No prices; not investment advice.